Market cap
₹28 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
2.5
Div. Yield
0 %
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
28 | 211 | 140 | 35 | 38,579 |
Revenue (₹ Cr) |
0 | 62 | 24 | 17 | 5,053 |
Net Profit (₹ Cr) |
-8.72 | 0.47 | -3.45 | 2.19 | 613.08 |
Net Margin (%) |
-17,442.00 | 0.75 | -14.04 | 12.01 | 11.89 |
RoE (%) |
-60.02 | 0.72 | -29.63 | 6.02 | 15.63 |
Price to Earnings |
-- | 446.48 | -- | 16.17 | 62.38 |
Price-To-Book |
2.48 | 3.45 | 12.65 | 0.90 | 8.92 |
Income Statement (₹ Cr)
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.02 | 61.94 | 24.07 | 16.90 | 5,053.19 |
|
Total Income
|
0.05 | 63.12 | 24.54 | 18.20 | 5,157.49 |
|
Total Expenditure
|
8.77 | 55.31 | 25.95 | 15.04 | 3,935.28 |
|
EBITDA
|
-8.75 | 6.63 | -1.87 | 1.86 | 1,117.91 |
|
Depreciation
|
0.00 | 5.42 | 1.64 | 0.55 | 267.48 |
|
EBIT
|
-8.75 | 1.21 | -3.52 | 1.30 | 850.43 |
|
Interest
|
0.00 | 1.72 | 0.40 | 0.06 | 102.98 |
|
Other Income
|
0.03 | 1.18 | 0.47 | 1.30 | 104.30 |
|
Exceptional Items
|
0.00 | 0.04 | 0.00 | 0.00 | -36.60 |
|
Profit before Tax
|
-8.72 | 0.71 | -3.45 | 2.55 | 815.15 |
|
Provision for Tax
|
0.00 | 0.24 | 0.00 | 0.37 | 202.07 |
|
Profit after Tax
|
-8.72 | 0.47 | -3.45 | 2.19 | 613.08 |
Liabilities (₹ Cr)
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
11.75 | 61.21 | 11.03 | 39.09 | 4,323.39 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 5.33 |
|
Non-Current Liabilities
|
0.09 | 22.13 | 4.51 | 0.00 | 1,495.04 |
|
Current Liabilities
|
2.54 | 17.24 | 3.68 | 2.99 | 768.03 |
|
Total Liabilities
|
14.38 | 82.60 | 18.51 | 35.47 | 5,905.00 |
Assets (₹ Cr)
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
11.84 | 61.32 | 9.57 | 39.45 | 3,286.77 |
|
Current Assets
|
2.54 | 11.58 | 5.25 | 2.51 | 2,088.60 |
|
Total Assets
|
14.38 | 82.60 | 18.51 | 35.47 | 5,905.00 |
|
Total Debt*
|
1.66 | 12.10 | 1.35 | 1.61 | 631.08 |
|
Net Current Assets
|
0.01 | -5.67 | 1.57 | -0.49 | 1,320.56 |
|
Contingent Liabilities
|
-- | 0.99 | 1.12 | 0.09 | 100.01 |
Cashflow (₹ Cr)
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-4.26 | 3.02 | 1.45 | 0.96 | 714.39 |
|
Cash Flow from Investing Activities
|
3.26 | -12.37 | -0.80 | -0.49 | -1,089.11 |
|
Cash from Financing Activities
|
2.63 | 9.03 | -1.14 | -1.42 | 271.85 |
|
Net Cash Inflow / Outflow
|
1.63 | -0.32 | -0.49 | -0.95 | -102.87 |
Ratios
Profitability Ratios
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-62.45 | 1.47 | 3.26 | 6.00 | 19.38 |
|
ROE (%)
|
-60.02 | 0.72 | -29.63 | 6.02 | 15.63 |
|
ROA (%)
|
-121.26 | 0.55 | -17.50 | 5.14 | 10.20 |
|
EBIT Margin (%)
|
-48,627.78 | 1.95 | -14.61 | 7.72 | 16.83 |
|
Net Margin (%)
|
-17,442.00 | 0.75 | -14.04 | 12.01 | 11.89 |
|
Cash Profit Margin (%)
|
-4.85 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 23.11 | -1.86 | 4.22 | 26.18 |
|
EBIT Growth (%)
|
-3,282.58 | 150.52 | -206.09 | 31.72 | 16.83 |
|
Net Profit Growth (%)
|
-3,247.46 | -30.13 | -201.29 | -55.37 | 9.16 |
|
EPS Growth (%)
|
-1,765.31 | -34.69 | -201.29 | -55.37 | 13.12 |
|
Book Value Growth (%)
|
-1.83 | 0.23 | 0.12 | -12.87 | 16.51 |
Valuation Ratios
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-3.48 | 481.69 | -40.51 | 16.17 | 59.58 |
|
Price / Book Value
|
2.48 | 3.45 | 12.65 | 0.90 | 8.92 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 3.32 | 0.03 |
|
EV/EBITDA
|
-3.25 | 33.10 | -74.33 | 19.17 | 34.06 |
|
Market Cap (₹ Cr)
|
36.08 | 210.77 | 57.49 | 42.75 | 25,841.07 |
Solvency Ratios
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.20 | 0.13 | 0.00 | 0.15 |
|
Short term debt to equity ratio
|
0.14 | -- | -- | 0.05 | -- |
|
Current Ratio
|
1.00 | 0.67 | 1.43 | 0.84 | 2.72 |
|
Quick Ratio
|
1.00 | 0.43 | 1.19 | 0.56 | 2.60 |
|
Interest Coverage
|
-7,532.35 | 1.41 | -7.55 | 46.55 | 8.92 |
Operating Efficiency Ratios
| Samsrita Labs | Lotus Eye Hosp | Aspira Pathlab | NG | Global Health | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
111.11 | 2.55 | 11.03 | 1.07 | 10.34 |
|
Asset Turnover
|
0.00 | 0.72 | 1.22 | 0.40 | 0.84 |
|
Receivable days
|
0.00 | 8.60 | 29.85 | 10.09 | 29.09 |
|
Inventory Days
|
0.00 | 26.04 | 8.83 | 17.46 | 6.05 |
|
Payable days
|
582.01 | 72.50 | 75.83 | 0.00 | 80.04 |
|
Cash Conversion Cycle
|
-582.01 | -37.86 | -37.16 | 27.55 | -44.90 |